12:00 AM
Apr 25, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

NanoViricides preclinical data

In mice lethally infected with influenza A (H1N1) virus, a trio of FluCide candidates significantly reduced the number of lung lesions by >95% vs. untreated controls (p<0.001), whereas mice treated with...

Read the full 135 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >